Press Release: Brnoteplase for Stroke Therapy

Scientists from the Loschmidt Laboratories, together with collaborators from Masaryk University and STROKE Brno, have engineered a promising new thrombolytic enzyme. Named after the city of Brno, Brnoteplase addresses key limitations of existing stroke therapies and has significantly outperformed the current standard treatment, alteplase, in preclinical models.

Read the full press release here.